CBLL (CeriBell) Research & Development: $21.06 Mil (TTM As of Mar. 2026)


CBLL CeriBell Inc CBLL
12 GF Score
Price $18.61
! 3 Warning Signs
View Full Analysis

What is CeriBell Research & Development?

CeriBell CBLL +1.20% 12 Research & Development is $21.06 Mil as of Mar. 2026. GuruFocus rates CBLL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CeriBell's Research & Development for the three months ended in Mar. 2026 was $6.16 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $21.06 Mil.

CeriBell  (NAS:CBLL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CeriBell Research & Development Related Terms

CeriBell Research & Development Historical Data

* Premium members only.

The historical data trend for CeriBell's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CeriBell Research & Development Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
7.24 9.00 13.56 19.14

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.25 4.85 4.98 5.06 6.16
CBLL
12GF Score
CeriBell Inc CBLL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CeriBell Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $21.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $21.06 Mil mean?
CeriBell (CBLL) has a Research & Development of $21.06 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on CeriBell and its competitors.
Is CeriBell's Research & Development too high?
CeriBell's current Research & Development is $21.06 Mil. Overall, CeriBell has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does CeriBell's Research & Development compare to LMRI and SIBN?
CeriBell's Research & Development of $21.06 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CeriBell and its competitors. CeriBell's current Research & Development is $21.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CeriBell stock overvalued right now?
CeriBell (CBLL) has a current Research & Development of $21.06 Mil. The current Research & Development is $21.06 Mil. CeriBell's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CeriBell (CBLL), the current Research & Development is $21.06 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CeriBell Business Description

Address 360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
12GF Score

Get the complete analysis for CBLL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.61
Price